Injecto Polymers IPO - Company Analysis
Injecto Polymers IPO under the SME IPO category is a book-built issue of Rs. 56.12 Cr by Injecto Polymers Limited, which is in the production of a wide variety of plastic packaging items and the exchange of PVC resins and plastic granules. The company produces polypropylene (PP) Woven Fabrics, PP Woven Bags, Biaxially Oriented Polypropylene (BoPP) Bags, Lino Bags, Low-Density and Polyester Pouches, Flexible Intermediate Bulk Container (FIBC) Bags, and non-woven bags, among others.
Numerous industries, including agriculture, construction, textiles, chemicals, food, medicines, cosmetics, and consumer goods, employ these products. The company mainly uses a business-to-business (B2B) model, offering customized packaging products in different sizes and forms according to client needs.
Injecto Polymers IPO Details
The Injecto Polymers IPO date of opening is 11 Sep 2026; its initial public offering will end on 16 Sep, IPO allotment on Sep 17 and refund initiation on Sep 18, 2026.
The Rs. 56.12 crore new SME IPO comprises a wholly fresh issue of 0.56 Cr shares.
The Injecto Polymers IPO listing date (expected) might be Monday, Sep 21, 2026, and the listing on the BSE and SME.
The Injecto Polymers IPO price band is Rs. 98 to Rs. 100.
IPO Timetable (Tentative)
|
Events |
Date |
|
IPO Opening Date |
Sep 11, 2026 |
|
IPO Closing Date |
Sep 16, 2026 |
|
IPO Allotment Date |
Sep 17, 2026 |
|
Refund Initiation |
Sep 18, 2026 |
|
IPO Listing Date |
Sep 21, 2026 |
Click to open demat account and apply for the IPO.
Company Financials
(Amount in Cr)
|
Particulars |
31 Mar 2026 |
31 Mar 2025 |
31 Mar 2024 |
|
Assets |
270.93 |
170.57 |
121.25 |
|
Total Income |
375.83 |
261.85 |
109.80 |
|
Profit After Tax |
16.01 |
8.11 |
4.44 |
|
EBITDA |
38.04 |
22.57 |
12.35 |
|
Net Worth |
63.34 |
47.33 |
21.22 |
|
Reserves and Surplus |
48.16 |
32.15 |
7.84 |
|
Total Borrowing |
165.19 |
101.11 |
83.35 |
Cash Flows
(Amount in Lac)
|
Net Cash Flow |
31 Mar 2026 |
31 Mar 2025 |
31 Mar 2024 |
|
Net Cash Flow Operating Activities |
(4,880.10) |
(1,689.56) |
(1,295.23) |
|
Net Cash Flow Investing Activities |
(307.29) |
(944.16) |
(291.64) |
|
Net Cash Flow Financing Activities |
5,178.99 |
2,631.40 |
1,584.10 |
Revenue Bifurcation
(Rs. in Lac)
(Source: RHP)
The Objective of the Issue
The Company desires to use the Net Proceeds from the Issue to fulfill its following goals:
-
Repayment/pre-payment, in full or in part, of certain outstanding borrowings availed by the Company. ~ Rs. 10 Cr.
-
Funding the Capital expenditure towards setting up phase IV at the existing manufacturing facility, Unit-I, situated at NH2 Bypass Road, Jaugram, Abujhati, Jamalpur, West Bengal. ~ Rs. 30.50 Cr.
-
General Corporate Purposes.
Listed Peers of Injecto Polymers Ltd.
|
Name of the Company |
Face value (₹) |
EPS Basic |
P/E Ratio (x) |
|
Emmbi Industries Limited |
10/- |
19.43 |
4.22 |
|
RDB Rasayans Limited |
10/- |
9.04 |
19.17 |
Valuation
|
KPI |
Value (Mar 31, 2026) |
|
ROE |
28.94% |
|
ROCE |
15.64% |
|
Debt/Equity |
2.61 |
|
RoNW |
41.73% |
|
PAT Margin |
4.26% |
|
EBITDA Margin |
10.13% |
Evaluation of P/E Ratio
Considering the period ended on FY 2026 with an EPS of Rs. 10.55 from the last year, the resulting P/E ratio is 9.47x.
|
Valuation Metric |
Pre IPO |
Post IPO |
|
EPS (₹) |
10.55 |
7.70 |
|
P/E (x) |
9.48 |
12.99 |
Explore the Shanti Inorganics IPO.
IPO's Strengths
-
Strong customer relationships.
-
Locational advantage of manufacturing units.
-
Quality standard certifications and quality testing.
-
Multi-product portfolio and customisation capabilities.
IPO's Weaknesses
-
A significant portion of revenue is derived from a limited number of customers and is heavily concentrated in Eastern India
-
High reliance on trading operations exposes the company to volatile product prices, low profit margins, and supply-demand fluctuations.
-
Dependent on a limited number of suppliers for raw materials, making the company vulnerable to supply disruptions and price swings
Injecto Polymers IPO GMP (Grey Market Premium)
Injecto Polymers IPO GMP today is Rs. 0 as of 10 September, 2026, while writing this information.
Injecto Polymers IPO Summary
|
IPO Opening & Closing Date |
11 Sep, 2026 to 16 Sep, 2026 |
|
Face Value |
Rs. 10 per Share |
|
Issue Price |
Rs. 98 to Rs. 100 per Share. |
|
Lot Size |
1200 Shares |
|
Issue Size |
56,12,400 Shares (Rs. 56 Cr) |
|
Offer for Sale |
- |
|
Fresh Issue |
53,29,200 Shares (Rs. 53 Cr) |
|
Market Makers |
2,83,200 Shares (Rs. 3 Cr) |
|
Issue Type |
Bookbuild Issue |
|
Registrar |
Integrated Registry Management Services Pvt. Ltd. |
IPO Lot Details
Retail investors can invest in a minimum and maximum of 2 Lots (2400 Shares) for Rs. 2,40,000, and in multiples thereof, while HNI investors can invest in a minimum of 3 Lots (3600 Shares) for Rs. 3,60,000.
|
Minimum Lot Investment (Retail) |
2 Lots |
|
Maximum Lot Investment (Retail) |
2 Lots |
|
HNI (Min) |
3 Lots |
Injecto Polymers IPO Allotment Status
To check the Injecto Polymers IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.
Using BSE Website - BSE IPO allotment status
Promoters And Management of Injecto Polymers Ltd.
-
Ramesh Kumar Rateria
-
Ashok Kumar Rateria
-
Suman Financial Advisory Pvt. Ltd.
-
Suman Towers Pvt. Ltd.
-
Vinayak Tie-Up Pvt. Ltd.
-
Nivedeeka Commercial Pvt. Ltd.
-
Bhagyashri Trading Pvt. Ltd.
|
Pre-Issue Promoter Shareholding |
88.14% |
|
Post-Issue Promoter Shareholding |
64.35% |
IPO Lead Managers
- Indcap Advisors Pvt. Ltd.
Dividend Policy
The company has not paid a dividend during the last three FYs.
Conclusion
Injecto Polymers IPO showcases steady financial growth with a diversified product portfolio and strong industry presence. However, high debt levels, customer concentration, and negative operating cash flows remain key concerns.
Other Related Blogs:-
Manika Plastech IPO
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To read the prospectus of the company and download the DRHP.
Click Here To Stay Updated With The Upcoming IPOs.
DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.
